OBJECTIVE: Changes in the normal-appearing white matter (NAWM) in multiple sclerosis (MS) may contribute to disease progression. Here, we systematically quantified ultrastructural and subcellular characteristics of the axon-myelin unit in MS NAWM and determined how this correlates with low grade inflammation. METHODS: Human brain tissue obtained with short post-mortem delay and fixation at autopsy enables systematic quantification of ultrastructural characteristics. In this study, we performed high-resolution immunohistochemistry and quantitative transmission electron microscopy to study inflammation and ultrastructural characteristics of the axon-myelin unit in MS NAWM (n=8) and control white matter (WM) in the optic nerve. RESULTS: In the...
Aims: Multiple sclerosis (MS) is a progressive inflammatory neurological disease affecting myelin, n...
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) that a...
Objective: To assess whether chronic white matter inflammation in patients with multiple sclerosis (...
OBJECTIVE: Changes in the normal-appearing white matter (NAWM) in multiple sclerosis (MS) may contri...
Objective: Multiple sclerosis (MS) is a chronic neuroinflammatory and neurodegenerative disease of u...
Multiple sclerosis (MS) pathophysiology includes inflammation, demyelination and neurodegeneration, ...
Studies of MS histopathology are largely dependent on suitable animal models. While light microscopi...
OBJECTIVE: Prominent inflammation with formation of ectopic B-cell follicle-like structures in the ...
BACKGROUND AND OBJECTIVES: To investigate whether white matter lesion activity, acute axonal damage,...
Multiple sclerosis (MS) is a chronic neuroinflammatory disease characterized by myelin loss and axon...
OBJECTIVE: Cortical grey matter (GM) pathology, involving demyelination and neurodegeneration, asso...
Objective Prominent inflammation with formation of ectopic B-cell follicle-like structures in the me...
Concluding remarks 1. What are the cellular substrates of DTI measured diffusivity alterations in no...
OBJECTIVE: Multiple sclerosis (MS) is considered a chronic inflammatory and demyelinating disease of...
The complex manifestations of chronic multiple sclerosis (MS)are due in part to widespread axonal ab...
Aims: Multiple sclerosis (MS) is a progressive inflammatory neurological disease affecting myelin, n...
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) that a...
Objective: To assess whether chronic white matter inflammation in patients with multiple sclerosis (...
OBJECTIVE: Changes in the normal-appearing white matter (NAWM) in multiple sclerosis (MS) may contri...
Objective: Multiple sclerosis (MS) is a chronic neuroinflammatory and neurodegenerative disease of u...
Multiple sclerosis (MS) pathophysiology includes inflammation, demyelination and neurodegeneration, ...
Studies of MS histopathology are largely dependent on suitable animal models. While light microscopi...
OBJECTIVE: Prominent inflammation with formation of ectopic B-cell follicle-like structures in the ...
BACKGROUND AND OBJECTIVES: To investigate whether white matter lesion activity, acute axonal damage,...
Multiple sclerosis (MS) is a chronic neuroinflammatory disease characterized by myelin loss and axon...
OBJECTIVE: Cortical grey matter (GM) pathology, involving demyelination and neurodegeneration, asso...
Objective Prominent inflammation with formation of ectopic B-cell follicle-like structures in the me...
Concluding remarks 1. What are the cellular substrates of DTI measured diffusivity alterations in no...
OBJECTIVE: Multiple sclerosis (MS) is considered a chronic inflammatory and demyelinating disease of...
The complex manifestations of chronic multiple sclerosis (MS)are due in part to widespread axonal ab...
Aims: Multiple sclerosis (MS) is a progressive inflammatory neurological disease affecting myelin, n...
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) that a...
Objective: To assess whether chronic white matter inflammation in patients with multiple sclerosis (...